Altman has been instrumental in the development of “truly robust guidelines for the reporting of clinical trials and wider clinical research studies”.
Prof. Doug Altman, founding director of the Centre for Statistics in Medicine in Oxford, U.K. has received the 2015 BMJ Lifetime Achievement for his contribution to improving reporting of health research.
Altman has been instrumental in the development of “truly robust guidelines for the reporting of clinical trials and wider clinical research studies,” noted GSK’s Global Head of Epidemiology Dr. Andrew Roddam, who presented the award on behalf of the sponsors.
Dr Fiona Godlee, Editor-in-chief of the The BMJ, said Professor Altman “has done more than anyone else to encourage researchers to fully report what they actually did, warts and all, rather than letting the best be the enemy of the good or, worse, pretending that research is perfect.”
Click here for the full release about the BMJ award winners.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.